144 related articles for article (PubMed ID: 37505911)
21. Correlation of optical coherence tomography parameters with clinical and radiological progression in patients with symptomatic optic pathway gliomas.
Fard MA; Fakhree S; Eshraghi B
Graefes Arch Clin Exp Ophthalmol; 2013 Oct; 251(10):2429-36. PubMed ID: 23736991
[TBL] [Abstract][Full Text] [Related]
22. Optic pathway gliomas in adults.
Shofty B; Constantini S; Bokstein F; Ram Z; Ben-Sira L; Freedman S; Vainer G; Kesler A
Neurosurgery; 2014 Mar; 74(3):273-9; discussion 279-80. PubMed ID: 24335817
[TBL] [Abstract][Full Text] [Related]
23. Optic Gliomas in Neurofibromatosis Type 1.
Parkhurst E; Abboy S
J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):334-338. PubMed ID: 27537249
[TBL] [Abstract][Full Text] [Related]
24. The role of visual electrodiagnostics in management of children with neurofibromatosis type 1.
Tekavčič Pompe M; Pečarič Meglič N; Šuštar Habjan M
Doc Ophthalmol; 2023 Apr; 146(2):121-136. PubMed ID: 36652041
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of racial disparities in pediatric optic pathway glioma incidence: Results from the Surveillance, Epidemiology, and End Results Program, 2000-2014.
Peckham-Gregory EC; Montenegro RE; Stevenson DA; Viskochil DH; Scheurer ME; Lupo PJ; Schiffman JD
Cancer Epidemiol; 2018 Jun; 54():90-94. PubMed ID: 29684801
[TBL] [Abstract][Full Text] [Related]
26. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.
Avery RA; Bouffet E; Packer RJ; Reginald A
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1034-8. PubMed ID: 23329671
[TBL] [Abstract][Full Text] [Related]
27. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
[TBL] [Abstract][Full Text] [Related]
28. Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study.
Henning AM; Handrup MM; Kjeldsen SM; Larsen DA; Ejerskov C
Orphanet J Rare Dis; 2021 Nov; 16(1):489. PubMed ID: 34809690
[TBL] [Abstract][Full Text] [Related]
29. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
Kalin-Hajdu E; Décarie JC; Marzouki M; Carret AS; Ospina LH
Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
[TBL] [Abstract][Full Text] [Related]
30. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas.
Chang L; El-Dairi MA; Frempong TA; Burner EL; Bhatti MT; Young TL; Leigh F
J AAPOS; 2010 Dec; 14(6):511-7. PubMed ID: 21168074
[TBL] [Abstract][Full Text] [Related]
31. Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.
Avery RA; Mansoor A; Idrees R; Trimboli-Heidler C; Ishikawa H; Packer RJ; Linguraru MG
Neurology; 2016 Dec; 87(23):2403-2407. PubMed ID: 27815398
[TBL] [Abstract][Full Text] [Related]
32. Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1.
Glombova M; Petrak B; Lisy J; Zamecnik J; Sumerauer D; Liby P
Brain Dev; 2019 Sep; 41(8):678-690. PubMed ID: 31000370
[TBL] [Abstract][Full Text] [Related]
33. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G
J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725
[TBL] [Abstract][Full Text] [Related]
34. [Neurofibromatosis type 1 and optic pathway gliomas. A series of 80 patients].
Pascual-Castroviejo I; Pascual-Pascual SI; Velázquez-Fragua R; Viaño J; García-Segura JM; Botella MP
Rev Neurol; 2008 May 1-15; 46(9):530-6. PubMed ID: 18446694
[TBL] [Abstract][Full Text] [Related]
35. Visual field outcomes in children treated for neurofibromatosis type 1-associated optic pathway gliomas: a multicenter retrospective study.
Heidary G; Fisher MJ; Liu GT; Ferner RE; Gutmann DH; Listernick RH; Kapur K; Loguidice M; Ardern-Holmes SL; Avery RA; Hammond C; Hoffman RO; Hummel TR; Kuo A; Reginald A; Ullrich NJ
J AAPOS; 2020 Dec; 24(6):349.e1-349.e5. PubMed ID: 33221469
[TBL] [Abstract][Full Text] [Related]
36. Pediatric Optic Pathway Gliomas: A Report From Northern Greece.
Panagopoulou P; Athanasiadis D; Αnastasiou Α; Zafeiriou D; Papakonstantinou Ε
J Pediatr Hematol Oncol; 2023 Nov; 45(8):445-451. PubMed ID: 37696004
[TBL] [Abstract][Full Text] [Related]
37. The Utility of Early Brain MRI for Patients with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Long-Term Follow-Up in a Tertiary Referral Hospital.
Rony C; Aharoni S; Halevy A
Neuropediatrics; 2022 Oct; 53(5):370-375. PubMed ID: 35381604
[TBL] [Abstract][Full Text] [Related]
38. Optical coherence tomography as a marker of vision in children with optic pathway gliomas.
Banc A; Stan C; Florian IS
Childs Nerv Syst; 2018 Jan; 34(1):51-60. PubMed ID: 28844094
[TBL] [Abstract][Full Text] [Related]
39. Optical coherence tomography in the diagnosis of optic pathway gliomas.
Parrozzani R; Clementi M; Kotsafti O; Miglionico G; Trevisson E; Orlando G; Pilotto E; Midena E
Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8112-8. PubMed ID: 24169000
[TBL] [Abstract][Full Text] [Related]
40. Role of visual evoked potentials and optical coherence tomography in the screening for optic pathway gliomas in patients with neurofibromatosis type I.
Vagge A; Camicione P; Pellegrini M; Gatti G; Capris P; Severino M; Di Maita M; Panarello S; Traverso CE
Eur J Ophthalmol; 2021 Mar; 31(2):698-703. PubMed ID: 32066268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
